Integrative Characterization of Immune-relevant Genes in Hepatocellular Carcinoma
Open Access
- 8 March 2021
- journal article
- research article
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. 000 (000), 000
- https://doi.org/10.14218/jcth.2020.00132
Abstract
Tumor microenvironment plays an essential role in cancer development and progression. Cancer immunotherapy has become a promising approach for the treatment of hepatocellular carcinoma (HCC). We aimed to analyze the HCC immune microenvironment characteristics to identify immune-related genetic changes.Keywords
This publication has 46 references indexed in Scilit:
- Target analysis by integration of transcriptome and ChIP-seq data with BETANature Protocols, 2013
- Inferring tumour purity and stromal and immune cell admixture from expression dataNature Communications, 2013
- A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis CJournal of Hepatology, 2013
- Prognostically relevant gene signatures of high-grade serous ovarian carcinomaJCI Insight, 2012
- Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cellsNucleic Acids Research, 2012
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1Nature, 2009
- WGCNA: an R package for weighted correlation network analysisBMC Bioinformatics, 2008
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trialThe Lancet Oncology, 2008
- Sorafenib in Advanced Hepatocellular CarcinomaThe New England Journal of Medicine, 2008
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005